GenScript, ACT Therapeutics partner to develop new CAR-T Cell therapies
GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Jul 22
GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…
13 Jul 22
Teva will pay $24.8m and supply generic overdose-reversal medicine Narcan worth $20m, while AbbVie will pay $13m to…
12 Jul 22
The agreement follows the US Food and Drug Administration (FDA) lifting the clinical hold on the Phase 1/2…
12 Jul 22
Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the…
11 Jul 22
The UK health regulator indicated Tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications, after vaccination…
11 Jul 22
As per the agreement, the companies will develop and market Zynlonta for all hematologic and solid tumour indications,…
08 Jul 22
Emergent will manufacture, sell, and distribute Ebanga in the US and Canada, while Ridgeback will serve as the…
08 Jul 22
With the acquisition of Seagen, Merck is enabled to widen its cancer drugs portfolio, which is currently led…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
07 Jul 22
The three companies formed a joint venture, dubbed Aurobac Therapeutics, which will develop both next-generation antimicrobials and diagnostics…
07 Jul 22
WuXi STA’s new oligonucleotide and peptide production facility supports its end-to-end Contract Research, Development, and Manufacturing Organization (CRDMO)…